A U.S. federal court has ruled the Drug Enforcement Administration (DEA) does not have to explain its position ahead of a trial in a lawsuit brought by the U.S. Hemp Industries Association over DEA jurisdiction on CBD. Hemp Industry Daily reported that Judge James Boasberg of U.S. District Court in Washington D.C. ruled that HIA and co-petitioner RE Botanicals were acting in an “unusual manner” in a motion requesting the DEA answer certain questions ahead of the trial. The DEA rule that led to the lawsuit would criminalize CBD hemp at any point in the production process when the material’s THC levels rise above the federal limit of 0.3%, under the U.S. Controlled Substances Act. U.S. lawmakers have said the DEA rule on THC violates the intent of the 2018 Farm Bill, which legalized industrial hemp in the USA.